Towards in vitro models for reducing or replacing the use of animals in drug testing

被引：38

作者：

Stresser, David M. ^{[1
,2
,3
]}

Kopec, Anna K. ^{[2
,3
,4
]}

Hewitt, Philip ^{[2
,3
,5
]}

Hardwick, Rhiannon N. ^{[2
,3
,6
]}

Van Vleet, Terry R. ^{[2
,3
,7
]}

Mahalingaiah, Prathap Kumar S. ^{[2
,3
,7
]}

O'Connell, Denice ^{[2
,8
,9
]}

Jenkins, Gary J. ^{[1
,2
,10
]}

David, Rhiannon ^{[2
,3
,11
]}

Graham, Jessica ^{[2
,12
,13
,14
]}

Lee, Donna ^{[2
,9
,14
]}

Ekert, Jason ^{[2
,3
,15
]}

Fullerton, Aaron ^{[2
,3
,16
]}

Villenave, Remi ^{[2
,3
,17
]}

Bajaj, Piyush ^{[2
,3
,18
]}

Gosset, James R. ^{[2
,3
,19
]}

Ralston, Sherry L. ^{[2
,9
,20
]}

Guha, Manti ^{[2
,3
,21
]}

Amador-Arjona, Alejandro ^{[2
,3
,21
]}

Khan, Kainat ^{[2
,3
,11
]}

Agarwal, Saket ^{[2
,3
,22
]}

Hasselgren, Catrin ^{[2
,13
,23
]}

Wang, Xiaoting ^{[2
,3
,24
]}

Adams, Khary ^{[2
,9
,25
]}

Kaushik, Gaurav ^{[2
,3
,26
]}

Raczynski, Arkadiusz ^{[2
,3
,27
]}

Homan, Kimberly A. ^{[2
,3
,28
]}

机构：

[1] AbbVie, Quantitat Translat & ADME Sci, N Chicago, IL 60064 USA

[2] Int Consortium Innovat & Qual Pharmaceut Dev IQ, N Chicago, IL 60064 USA

[3] IQ Microphysiol Syst Affiliate IQ, N Chicago, IL 60064 USA

[4] Pfizer Inc, Drug Safety Res & Dev, Groton, CT USA

[5] Merck KGaA, Chem & Preclin Safety, Darmstadt, Germany

[6] Bristol Myers Squibb, Pharmaceut Candidate Optimizat, Discovery Toxicol, San Diego, CA USA

[7] AbbVie, Investigat Toxicol & Pathol, N Chicago, IL USA

[8] AbbVie, Global Anim Welf, N Chicago, IL 60064 USA

[9] IQ 3Rs Replacement Reduct Refinement Translat & P, N Chicago, IL USA

[10] IQ Translat & ADME Sci Leadership Grp TALG, N Chicago, IL USA

[11] AstraZeneca, Clin Pharmacol & Safety Sci, Cambridge, England

[12] Genentech Inc, Prod Qual & Occupat Toxicol, San Francisco, CA 94080 USA

[13] IQ DruSafe, N Chicago, IL USA

[14] Genentech Inc, Safety Assessment, San Francisco, CA 94080 USA

[15] UCB Pharma, Cambridge, MA USA

[16] Genentech Inc, Investigat Toxicol, San Francisco, CA 94080 USA

[17] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland

[18] Sanofi, Global Investigat Toxicol, Preclin Safety, Cambridge, MA USA

[19] Pfizer Inc, Pharmacokinet Dynam & Metab, Med Design, Cambridge, MA USA

[20] AbbVie, Preclin Safety, N Chicago, IL 60064 USA

[21] Incyte, Discovery Biol, Wilmington, DE USA

[22] Alnylam Pharmaceut, Investigat Toxicol, Early Dev, Cambridge, MA USA

[23] Genentech Inc, Predict Toxicol, San Francisco, CA 94080 USA

[24] Amgen Inc, Translat Safety & Bioanalyt Sci, Amgen Res, San Francisco, CA USA

[25] Incyte, Lab Anim Resources, Wilmington, DE USA

[26] Boehringer Ingelheim Pharmaceut Inc, Nonclin Drug Safety, Ridgefield, CT USA

[27] Vertex Pharmaceut Inc, Preclin Safety Assessment, Boston, MA USA

[28] Genentech Inc, Complex In Vitro Syst Grp, San Francisco, CA 94080 USA

来源：

NATURE BIOMEDICAL ENGINEERING | 2024年 / 8卷 / 08期

关键词：

MICROPHYSIOLOGICAL SYSTEMS; INDUSTRY PERSPECTIVE; CLINICAL-TRIALS; SAFETY; CONSORTIUM; CHIP; PHARMACOKINETICS; SUPPORT; UTILITY;

D O I：

10.1038/s41551-023-01154-7

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Pharmaceutical companies continue to advocate for the use of in vitro models towards the reduction of animal use in drug discovery and development while acknowledging that further advancements are needed to heighten the models' current state of readiness.

引用

页码：930 / 935

页数：6

共 50 条

[41] The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry - Background and current status in the drug discovery process
Lundquist, S
Renftel, M
VASCULAR PHARMACOLOGY, 2002, 38 (06) : 355 - 364
[42] Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery
Silvestri, Alessandra
Vicente, Francisca
Vicent, Maria J.
Stechmann, Bahne
Fecke, Wolfgang
DRUG DISCOVERY TODAY, 2021, 26 (06) : 1369 - 1381
[43] In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration
Joubert, Ruan
Steyn, Johan Dewald
Heystek, Hendrik Jacobus
Steenekamp, Jan Harm
Du Preez, Jan Lourens
Hamman, Josias Hendrik
EXPERT OPINION ON DRUG DELIVERY, 2017, 14 (02) : 179 - 187
[44] Designing a novel in vitro drug-release-testing method for liposomes prepared by pH-gradient method
Nakamura, Koji
Yoshino, Keisuke
Yamashita, Keiko
Kasukawa, Hiroaki
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 430 (1-2) : 381 - 387
[45] The PK-Eye: A Novel In Vitro Ocular Flow Model for Use in Preclinical Drug Development
Awwad, Sahar
Lockwood, Alastair
Brocchini, Steve
Khaw, Peng T.
JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (10) : 3330 - 3342
[46] Use of in silico models for prioritization of heat-induced food contaminants in mutagenicity and carcinogenicity testing
Frenzel, Falko
Buhrke, Thorsten
Wenzel, Irina
Andrack, Jennifer
Hielscher, Jan
Lampen, Alfonso
ARCHIVES OF TOXICOLOGY, 2017, 91 (09) : 3157 - 3174
[47] Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes
Basheer, Loai
Schultz, Keren
Fichman, Merav
Kerem, Zohar
PLOS ONE, 2015, 10 (10):
[48] Attitudes towards drug-eluting stent use and the distribution of motivation type among interventional cardiologists
Qian, Feng
Phelps, Charles E.
Ling, Frederick S.
Hannan, Edward L.
Veazie, Peter J.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2012, 18 (03) : 528 - 533
[49] Reducing the Number of Laboratory Animals Used in Tissue Engineering Research by Restricting the Variety of Animal Models. Articular Cartilage Tissue Engineering as a Case Study
de Vries, Rob B. M.
Buma, Pieter
Leenaars, Marlies
Ritskes-Hoitinga, Merel
Gordijn, Bert
TISSUE ENGINEERING PART B-REVIEWS, 2012, 18 (06) : 427 - 435
[50] In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel
Murphy, Diarmaid J.
Bashi, Yahya H. Dallal
McCoy, Clare F.
Boyd, Peter
Brown, Leeanne
Martin, Francois
McMullen, Nicole
Kleinbeck, Kyle
Dangi, Bindi
Spence, Patrick
Hansraj, Bashir
Devlin, Brid
Malcolm, R. Karl
INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2022, 4

← 1 2 3 4 5 →